Absent immunoglobulins in HIV-related Burkitt lymphoma/leukaemia.
Shimomura
Akihiko
A
Lilienfeld-Toal
Marie von
Mv
Balta
Zeynep
Z
Schroers
Elisabeth
E
Schmidt-Wolf
Ingo G H
IG
Büttner
Reinhard
R
Rücker
Alexander von
Av
Gütgemann
Ines
I
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D023241:Antiretroviral Therapy, Highly Active; D001402:B-Lymphocytes; D001772:Blood Cell Count; D001853:Bone Marrow / Q000378:metabolism / Q000473:pathology; D002051:Burkitt Lymphoma / Q000097:blood* / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D015658:HIV Infections / Q000097:blood* / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D007136:Immunoglobulins / Q000097:blood*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D013713:Teniposide / Q000008:administration & dosage
D007136:Immunoglobulins; D003561:Cytarabine; D003907:Dexamethasone; D003520:Cyclophosphamide; D013713:Teniposide; D011239:Prednisolone; D007069:Ifosfamide; D008727:Methotrexate